COUNT
WHO recommends highly successful COVID-19 therapy; calls for wide geographical distribution, transparency from originator
May 2, 2022 9:46 p.m.
WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk of hospital admission, calling it the best therapeutic choice for high-risk patients to date.
However, availability, lack of price transparency in bilateral deals made by the producer, and the need for prompt and accurate testing before administering it, are turning this life-saving medicine into a major challenge for low- and middle-income countries.
Pfizer’s oral antiviral drug (a combination of nirmatrelvir and ritonavir tablets) is strongly recommended for patients with non-severe COVID-19 who are at highest risk of developing severe disease and hospitalization, such as unvaccinated, older, or immunosuppressed patients.
This recommendation is based on new data from two randomized controlled trials involving 3078 patients.
The data show that the risk of hospitalization is reduced by 85% following this treatment. In a high-risk group (over 10% risk of hospitalization), that means 84 fewer hospitalizations per 1000 patients.
WHO suggests against its use in patients at lower risk, as the benefits were found to be negligible.
One obstacle for low- and middle-income countries is that the medicine can only be administered while the disease is at its early stages; prompt and accurate testing is therefore essential for a successful outcome with this therapy.
Data collected by FIND show that the average daily testing rate in low-income countries is as low as one-eightieth the rate in high-income countries. Improving access to early testing and diagnosis in primary health care settings will be key for the global rollout of this treatment.
WHO is extremely concerned that — as occurred with COVID-19 vaccines — low- and middle-income countries will again be pushed to the end of the queue when it comes to accessing this treatment.
Lack of transparency on the part of the originator company is making it difficult for public health organizations to obtain an accurate picture of the availability of the medicine, which countries are involved in bilateral deals and what they are paying.
In addition, a licensing agreement made by Pfizer with the Medicines Patent Pool limits the number of countries that can benefit from generic production of the medicine.
The originator product, sold under the name Paxlovid, will be included in the WHO prequalification list today, but generic products are not yet available from quality-assured sources.
Several generic companies (many of which are covered by the licensing agreement between the Medicines Pool and Pfizer) are in discussion with WHO Prequalification but may take some time to comply with international standards so that they can supply the medicine internationally.
WHO therefore strongly recommends that Pfizer make its pricing and deals more transparent and that it enlarge the geographical scope of its licence with the Medicines Patent Pool so that more generic manufacturers may start to produce the medicine and make it available faster at affordable prices.
Along with the strong recommendation for the use of nirmatrelvir and ritonavir, WHO has also updated its recommendation on remdesivir, another antiviral medicine.
Previously, WHO had suggested against its use in all COVID-19 patients regardless of disease severity, due to the totality of the evidence at that time showing little or no effect on mortality.
Following publication of new data from a clinical trial looking at the outcome of admission to hospital, WHO has updated its recommendation. WHO now suggests the use of remdesivir in mild or moderate COVID-19 patients who are at high risk of hospitalization.
The recommendation for use of remdesivir in patients with severe or critical COVID-19 is currently under review. (From World Health Organization)
COUNT
Tesla Cybertruck winner bought 10 units of HONOR X9d 5G
2:56 p.m. April 21, 2026
Global leading AI device brand HONOR handed over the coveted Tesla Cybertruck to the winner of the HONOR X9d 5G “Win A Tesla Cybertruck” promo that ran during the toughest phone’s pre-order period January 9 to 23, 2026.
“The HONOR X9d 5G is our biggest win this year, and it continues to stand out in its category with its ultra-tough build, engineered to withstand everyday drops and pressure, making it a reliable companion for users with active lifestyles. This awarding marked a milestone not only for us, but also to our growing community of Filipino fans,” said HONOR Philippines Vice President Stephen Cheng.
Launched as part of HONOR’s effort to bring excitement to the Filipino market, the HONOR X9d 5G Win-A-Tesla Cybertruck promo captured nationwide attention, drawing strong participation from consumers eager to experience the smartphone’s exceptional durability, long-lasting battery life, and sleek design—while also getting a chance to win a once-in-a-lifetime prize.
The much-anticipated turnover celebrated excitement and the rewarding experience that HONOR continues to bring to its consumers. The grand winner, Lorelyn Felonia, who purchased 10 pieces of HONOR X9d 5G during the promo period, drove home not just a powerful smartphone but also one of the rarest vehicles in the world.
To award the multi-million prize were HONOR Philippines Country Manager Sean Yuan, Digital Marketing Manager and Content Lead Eason De Guzman.
With the successful conclusion of the campaign, HONOR Philippines looks forward to launching more exciting initiatives that combine cutting-edge technology with equally compelling rewards to its loyal HONOR fans.
To learn more about this exciting news, visit HONOR’s website www.hihonor.com, and follow HONOR Philippines on Facebook (Facebook.com/HonorPhilippines), Instagram (Instagram.com/honorph/) and TikTok: (Tiktok.com/@honorphilippines) for exclusive teasers, launch updates, and big reveal.
COUNT
#GCashTipidTips: DOTr-mandated 50% discounted MRT-3 fares can be availed via GCash
6:15 p.m. April 18, 2026
STARTING April 23, the Department of Transportation (DOTr) has implemented a discounted fare matrix for single-journey tickets, stored-value cards, and cashless payments in response to rising consumer prices.
Passengers of Metro Rail Transit Line 3 (MRT-3) can easily avail of the discounted fare via the GCash app by using the GCash Commute QR, NFC-enabled Android phone, or GCash Visa card. Commuters can skip the ticketing booth lines and go directly to the platforms, making travel more convenient and seamless.
The GCash payment schemes have been up and running at MRT-3 since July last year, providing commuters with cashless options for their daily travels.
The goal is simple: to make everyday transactions more affordable, accessible, and seamless for Filipinos.
For more information, please visit https://help.gcash.com/hc/en-us/articles/49102305024025-Can-I-use-GCash-for-transportation
COUNT
DigiPlus levels up user engagement with ArenaPlus’ P1B Prediction Giveaway
5:10 p.m. April 7, 2026
DigiPlus Interactive Corp., the country’s pioneer and leader in digital entertainment, through its flagship sportsbook platform ArenaPlus, formally launched its P1 Billion Prediction Giveaway last Saturday, March 21, heralding a major step-up in its customer acquisition and retention strategy.
This initiative is anchored by a high-stakes prediction challenge designed to invite new users onto ArenaPlus, while also deepening player participation and reinforcing brand leadership in the Philippine online sportsbook space. Central to this campaign is the introduction of a localized tournament bracket game—a staple in American sports culture that ArenaPlus is pioneering for the local market.
“We want to bring some excitement for the Filipino basketball fans, especially since we know that the NBA is the most popular sport here. The bracket game is actually very common in the US. It’s been running there constantly for years, but the Philippines has never had that experience. We want to bring that here,” said ArenaPlus Head Erick Su.
By offering the ₱1 Billion Prediction Giveaway as a free-to-play initiative, DigiPlus enables fans to engage in the tournament without any monetary commitment. Su emphasized that the campaign is designed to provide a safe, entertainment-led experience, with the bracket format sustaining interest from the opening round of the Playoffs through the Finals, where one team ultimately prevails.
“I think the excitement will be from beginning to the end. Because the bracket game covers the whole stage of the Playoffs, fans can expand their predictions and go along with the whole process and expect that they can win,” Su said. “So that’s going to bring a lot of excitement. And this is completely free and very safe as we want to entertain Filipinos.”
Amplifying the campaign that launched at Mall of Asia Sky Deck Amphitheater in Pasay City was premier host and actor Luis “Lucky” Manzano, who was also introduced as ArenaPlus’ latest brand ambassador. Joining Manzano were fellow endorsers Gilas Pilipinas naturalized player Justin Brownlee, multi-time champion assistant coach Bong Ravena, and his son, international pro Thirdy, who are effectively raising ArenaPlus’ visibility while also broadening the brand’s demographic reach.
“At ArenaPlus, we are relentless with our commitment to elevate our players’ experience, making sports more fulfilling, more immersive, and more rewarding for every Filipino,” said ArenaPlus Marketing Head Hannah Bagui as ArenaPlus continues to differentiate itself by pioneering accessible digital sports entertainment.
While the campaign is designed to drive wide participation, ArenaPlus emphasized that it intends to maintain strict platform integrity through its rigorous eKYC (electronic Know Your Customer) process. Such a guardrail bolsters an already rich suite of responsible gaming tools built into ArenaPlus, such as options to set daily gaming durations, customize specific gaming schedules, and establish daily loss limits. This ensures that while the campaign achieves great reach, it does so within a secure, transparent, and compliant environment that builds trust.
Through these strategic customer activations and continuous platform innovation, DigiPlus Interactive Corp. continues to solidify its legacy as the definitive pioneer of the Philippine digital entertainment industry, driving growth while also redefining user engagement
Gen Z is Google’s most active users as AI transforms Search into an intelligent partner
Motorcycle taxi riders urge government to protect livelihoods, enact motorcycle taxi bill
All-new MacBook Neo launches at Power Mac Center
